Erasca (ERAS) Total Liabilities (2020 - 2026)
Erasca (ERAS) reported Total Liabilities of $67.7 million for Q1 2026, down 5.63% on a YoY basis from $71.7 million in Q1 2025, and down 4.62% quarter-over-quarter from $71.0 million in Q4 2025.
Erasca (ERAS) Total Liabilities (2020 - 2026) Analysis & Trends
Erasca has reported Total Liabilities for 7 years, with the latest figure at $67.7 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 5.63% year-over-year to $67.7 million; the trailing twelve-month figure through Mar 2026 stood at $67.7 million (down 5.63% YoY), and the FY2025 full-year result was $71.0 million, down 10.18% from the prior year.
- Total Liabilities for Q1 2026 stood at $67.7 million, down from $71.0 million in the prior quarter.
- The five-year high for Total Liabilities was $103.1 million in Q4 2022, with the low at $49.8 million in Q2 2022.
- Historically, Total Liabilities has averaged $74.9 million across 5 years, with a median of $78.0 million in 2023.
- The largest YoY upside for Total Liabilities was 154.09% in 2022 against a maximum downside of 60.69% in 2022.
- Erasca's Total Liabilities stood at $103.1 million in 2022, then retreated by 23.72% to $78.6 million in 2023, then increased by 0.53% to $79.0 million in 2024, then slipped by 10.18% to $71.0 million in 2025, then fell by 4.62% to $67.7 million in 2026.
- The last three Total Liabilities figures came in at $67.7 million (Q1 2026), $71.0 million (Q4 2025), and $72.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - | 67.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.71 Mn |
| Dec 31, 2025 | 70.98 Mn |
| Sep 30, 2025 | 72.52 Mn |
| Jun 30, 2025 | 73.13 Mn |
| Mar 31, 2025 | 71.74 Mn |
| Dec 31, 2024 | 79.03 Mn |
| Sep 30, 2024 | 78.85 Mn |
| Jun 30, 2024 | 74.66 Mn |
| Mar 31, 2024 | 81.61 Mn |
| Dec 31, 2023 | 78.61 Mn |
| Sep 30, 2023 | 80.43 Mn |
| Jun 30, 2023 | 77.96 Mn |
| Mar 31, 2023 | 81.09 Mn |
| Dec 31, 2022 | 103.06 Mn |
| Sep 30, 2022 | 81.11 Mn |
| Jun 30, 2022 | 49.76 Mn |
| Mar 31, 2022 | 50.81 Mn |
| Dec 31, 2021 | 44.89 Mn |
| Sep 30, 2021 | 38.96 Mn |
| Jun 30, 2021 | 19.58 Mn |